188 Results for "

PPIs

" in MedChemExpress (MCE) Product Catalog:
Products (188)

188 Results for "PPIs" in MCE Product Catalog:

Cat. No.: HY-124191
CAS No.: 1303533-81-4
Purity:  99.94%
Synonyms: PPI-668 hydrochloride
Target:  

HCV

Research Areas:  

Infection

Ravidasvir hydrochloride (PPI-668 hydrochloride) is a pan-genotypic inhibitor for hepatitis C virus (HCV) NS5A protein. Ravidasvir hydrochloride inhibits the replication of HCV, with EC50 of 0.12, 0.01 and 1.14 nM, for HCV gt-1a, gt-1b, and gt-3a replicons, respectively. Ravidasvir hydrochloride exhibits good pharmacokinetic characters in rats .
loading...
    loading...
Cat. No.: HY-13731
CAS No.: 431077-35-9
Purity:  99.67%
Target:  

MetAP

Research Areas:  

Inflammation/Immunology Cancer

PPI-2458 is a potent, orally active, selective and irreversible inhibitor of methionine aminopeptidase-2 (MetAP-2). PPI-2458 can be used for arthritis and lymphoma research .
loading...
    loading...
Cat. No.: HY-160477
CAS No.: 300713-88-6
Target:  

PIKfyve NF-κB IKK

Research Areas:  

Inflammation/Immunology

DC-SX029 is a potent SNX10 protein-protein interaction (PPI) inhibitor with oral activity with an estimated KD constant of ~0.935 μM by surface plasmon resonance (SPR). DC-SX029 blocks the SNX10-PIKfyve interaction, thereby decreased the TBK1/c-Rel signaling activation. DC-SX029 does not affect the protein level of SNX10. DC-SX029 has the potential for inflammatory bowel disease (IBD) research .
loading...
    loading...
Cat. No.: HY-151576
CAS No.: 3031536-71-4
Purity:  98.70%
Research Areas:  

Cancer

PRMT5:MEP50 PPI is a novel PRMT5:MEP50 protein-protein interaction (PRMT5:MEP50 PPI) inhibitor, shows anti-tumor activity and anti-proliferative activity of lung and prostate cancer cells .
loading...
    loading...
Cat. No.: HY-122579
CAS No.: 313480-47-6
Purity:  98.57%
Target:  

Calmodulin

Research Areas:  

Others

IGS-1.76 efficiently inhibits the human NCS-1/Ric8a complex. IGS-1.76 shows a significantly increased affinity for hNCS-1 and is able to modulate the hNCS-1/Ric8a interaction efficiently .
loading...
    loading...
Cat. No.: HY-169784
CAS No.: 1436673-69-6
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease

PPI-1040 is an orally bioavailable vinyl ether synthetic plasmalogen. PPI-1040 acts as a precursor of plasmalogen. PPI-1040 increases plasmalogen levels in plasmalogen-deficient mice and normalizes hyperactive behaviors in these mice. In wild-type mice, PPI-1040 retains the sn-1 vinyl ether group and sn-3 phosphoethanolamine group, and is converted into endogenous ethanolamine plasmalogen. PPI-1040 can be used in studies related to rhizomelic chondrodysplasia punctata .
loading...
    loading...
Cat. No.: HY-132300A
CAS No.: 2632259-92-6
Purity:  99.42%
Target:  

β-catenin

Research Areas:  

Cancer

ZW4864 (free base) is an orally active and selective β catenin/B-Cell lymphoma 9 protein protein interaction (β catenin/BCL9 PPI) inhibitor. ZW4864 (free base) inhibits β catenin/BCL9 PPI with a Ki value of 0.76 μM and an IC50 value of 0.87 μM .
loading...
    loading...
Cat. No.: HY-119424
CAS No.: 515846-21-6
Purity:  98.11%
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

SP4206 is an IL-2/IL-2Rα interaction inhibitor. SP4206 binds with high affinity (Kd=70 nM) to IL-2 and blocks binding to its natural receptor IL-2Rα (Kd=10 nM) .
loading...
    loading...
Cat. No.: HY-D2277
CAS No.: 1394821-44-3
Fluorescein-CM2 is a fluorogenic molecule that can be used to rapidly screen esterase cut sites for protein-protein interaction-dependent (PPI-dependent) esterase activity in E. coli .
loading...
    loading...
Cat. No.: HY-P1190
CAS No.: 610273-01-3
Target:  

JNK Apoptosis

Research Areas:  

Inflammation/Immunology

c-JUN peptide is a cell-permeable c-JUN-JNK interaction inhibitor. c-JUN peptide inhibits serum-induced c-Jun phosphorylation. c-JUN peptide induces apoptosis .
loading...
    loading...
Cat. No.: HY-158005
Target:  

Apoptosis

Research Areas:  

Cancer

Anticancer agent 195 (Compound 10) is an inhibitor for ELF3-MED23 PPI with Ki of 0.68 μM. Anticancer agent 195 induces apoptosis and exhibits antitumor activity .
loading...
    loading...
Cat. No.: HY-161011
CAS No.: 1557337-03-7
Target:  

Arp2/3 Complex

Research Areas:  

Others

Spire2/FMN2 PPI-IN-1 (Compound 13) is a selective inhibitory fragment targeting the Spire2-FMN2 interaction, with an IC50 of 62 μM. Spire2/FMN2 PPI-IN-1 has affinity for KIND2, with a Kd of 87.7 μM, and does not inhibit KIND1. Spire2/FMN2 PPI-IN-1 can be used for the development of chemical probes for the Spire2-FMN2 interaction .
loading...
    loading...
Cat. No.: HY-155531
CAS No.: 3052256-03-5
Research Areas:  

Infection

PEX5-PEX14 PPI-IN-2 (compound 12) is a PEX14-PEX5 protein-protein interaction (PPI) inhibitor. PEX5-PEX14 PPI-IN-2 inhibits PEX14-PEX5 PPI with EC50 values of 5 and 17 µM in T. b. brucei and HepG2 cells, respectively. PEX5-PEX14 PPI-IN-2 can be used in the research of diseases related to trypanosome infection .
loading...
    loading...
Cat. No.: HY-151525
CAS No.: 2714432-83-2
Purity:  98.99%
Target:  

YAP

Research Areas:  

Cancer

YAP-TEAD-IN-2 (compound 6) is a potent YAP-TEAD PPI (protein-protein interaction) inhibitor with IC50 is 2.7 nM .
loading...
    loading...
Cat. No.: HY-118244
CAS No.: 1419321-16-6
Target:  

Dynamin

Research Areas:  

Others

Clathrin-IN-3 (Compound 25) is a Clathrin inhibitor (IC50: 6.9 μM). Clathrin-IN-3 potenly inhibits clathrin terminal domain-amphiphysin PPI .
loading...
    loading...
Cat. No.: HY-138562
CAS No.: 13728-56-8
Purity:  98.60%
Target:  

HIV

Research Areas:  

Infection

HIV-1 Nef-IN-1 is an HIV-1 Nef protein inhibitor that efficiently competes for Nef-SH3Hck interactions with a Kd of 6.7 μM .
loading...
    loading...
Cat. No.: HY-155530
CAS No.: 3052256-26-2
Target:  

Bacterial

Research Areas:  

Infection

PEX5-PEX14 PPI-IN-1 (Compound 8) is a PEX14-PEX5 PPI inhibitor. PEX5-PEX14 PPI-IN-1 disrupts the PEX5-TbPEX14 PPI with a Ki of 53 μM. PEX5-PEX14 PPI-IN-1 inhibits the bloodstream form of T. b. brucei (EC50: 5 μM) .
loading...
    loading...
Cat. No.: HY-P991210
CAS No.: 2746354-58-3
Synonyms: ALXN-1850

Target:  

Phosphatase

Research Areas:  

Cardiovascular Disease

Efzimfotase alfa (ALXN-1850) is enzyme replacement therapy agent targeting the deficiency of tissue-nonspecific alkaline phosphatase (TNSALP). Efzimfotase alfa functions by hydrolyzing the substrates of TNSALP, reducing the concentrations of substrates such as inorganic pyrophosphate (PPi) and pyridoxal 5′-phosphate (PLP). Efzimfotase alfa is promising for research of hypophosphatasia (HPP) .
loading...
    loading...
Cat. No.: HY-178172
AF9/ENL-DOT1L/AF4 PPI-IN-1 is a potent AF9/ENL and histone methyltransferase DOT1L/AF4 protein-protein interactions (PPI) inhibitor. AF9/ENL-DOT1L/AF4 PPI-IN-1 can inhibit the AF9-DOT1L (IC50 = 1.5 μM), AF9-AF4 (IC50 = 1 μM), ENL-AF4 (IC50 = 1.2 μM) interactions. AF9/ENL-DOT1L/AF4 PPI-IN-1 can suppress the expression of Mixed lineage leukemia (MLL) target genes Myc and Meis1 and selectively block the proliferation of MLL-r and several other leukemia cells. AF9/ENL-DOT1L/AF4 PPI-IN-1 exhibits significant antitumor activities in a mouse model of MLL-r leukemia without overt toxicities. AF9/ENL-DOT1L/AF4 PPI-IN-1 can be used for the study of MLL-r leukemia .
loading...
    loading...
Cat. No.: HY-B0656S
CAS No.: 934295-48-4
Synonyms: LY307640-d4
Rabeprazole-d4 is a deuterium labeled Rabeprazole. Rabeprazole is a second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. Rabeprazole induces apoptosis. Rabeprazole acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM. Rabeprazole can be used for the research of gastric ulcerations and gastroesophageal reflux .
loading...
    loading...